
Number of publications published per year by Herrmann, Eva. (Source : PubMed)

Distribution of publications types for Herrmann, Eva. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Response to letter: on the validity of meta-analysis.
J Clin Epidemiol
2010;63;3
Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trial.
BJU Int.
2010


Assessment of liver fibrosis and steatosis in PBC with FibroScan, MRI, MR-spectroscopy, and serum markers.
J. Clin. Gastroenterol.
2010;44;1

Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus-infected patients.
Hepatology
2009;50;6

Interleukin-2 in CD8+ T cells correlates with Banff score during organ rejection in liver transplant recipients.
Clin. Exp. Med.
2009;9;4
Methotrexate for maintenance of remission in chronic active Crohn's disease: Long-term single-center experience and meta-analysis of observational studies.
Inflamm. Bowel Dis.
2009
Real-time tissue elastography versus FibroScan for noninvasive assessment of liver fibrosis in chronic liver disease.
Ultraschall Med
2009;30;5
Endothelin-A-receptor antagonism with atrasentan exhibits limited activity on the KU-19-19 bladder cancer cell line in a mouse model.
J. Cancer Res. Clin. Oncol.
2009;135;10
Effect of ribavirin on the frequency of RNase L cleavage sites within the hepatitis C viral genome.
J. Viral Hepat.
2009

The role of lymphangiogenesis in lymphatic tumour spread of urological cancers.
BJU Int.
2009;104;5
[ See timeline ] [ See all publications ]
means that Herrmann, Eva has 18 papers cited a least 18 times - methodology
University of Münster, Münster, Germany.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.